← Back to Analyst Consensus 
SNDX Buy
Syndax Pharmaceuticals Inc
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Oct 29, 2026 (2 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 21, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Aug 11, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Aug 5, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 15, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 12, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 22, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 13, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 1, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 1, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Mar 31, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Mar 9, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Mar 2, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Jan 27, 2026 | Mizuho | maintain | Outperform → Outperform | $600 | 52% |
| Dec 9, 2025 | BTIG | reiterate | Buy → Buy | $56 | 52% |
| Nov 24, 2025 | Barclays | maintain | Overweight → Overweight | $35 | 53% |
| Nov 12, 2025 | JP Morgan | maintain | Overweight → Overweight | $33 | 55% |
| Nov 4, 2025 | UBS | maintain | Buy → Buy | $38 | 54% |
| Nov 4, 2025 | Barclays | maintain | Overweight → Overweight | $22 | 53% |
| Oct 27, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Oct 27, 2025 | BTIG | reiterate | Buy → Buy | $56 | 52% |
| Sep 19, 2025 | BTIG | reiterate | Buy → Buy | $56 | 52% |
| Sep 5, 2025 | Goldman Sachs | maintain | Buy → Buy | $24 | 54% |
| Sep 4, 2025 | Guggenheim | initiate | — → Buy | $34 | 52% |
| Aug 5, 2025 | Citigroup | maintain | Buy → Buy | $51 | 54% |
| Aug 5, 2025 | BTIG | maintain | Buy → Buy | $56 | 52% |
| Jul 15, 2025 | UBS | maintain | Buy → Buy | $35 | 54% |
| Jul 10, 2025 | Goldman Sachs | initiate | — → Buy | $18 | 54% |
| May 6, 2025 | Scotiabank | maintain | Sector Perform → Sector Perform | $17 | 55% |
| May 6, 2025 | Guggenheim | reiterate | Buy → Buy | $32 | 52% |
| Mar 20, 2025 | JP Morgan | maintain | Overweight → Overweight | $41 | 55% |
| Mar 4, 2025 | JP Morgan | maintain | Overweight → Overweight | $39 | 55% |
| Mar 4, 2025 | Citigroup | maintain | Buy → Buy | $42 | 54% |
| Mar 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
| Jan 8, 2025 | Scotiabank | maintain | Sector Perform → Sector Perform | $16 | 55% |
| Dec 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
| Nov 21, 2024 | JP Morgan | maintain | Overweight → Overweight | $38 | 55% |
| Nov 19, 2024 | Citigroup | maintain | Buy → Buy | $45 | 54% |
| Nov 18, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $51 | 44% |
| Nov 12, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $49 | 44% |
| Nov 7, 2024 | Goldman Sachs | maintain | Buy → Buy | $33 | 54% |
| Nov 6, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $47 | 44% |
| Oct 24, 2024 | UBS | initiate | — → Buy | $37 | 54% |
| Oct 14, 2024 | Stifel | maintain | Buy → Buy | $41 | 53% |
| Aug 16, 2024 | Citigroup | maintain | Buy → Buy | $34 | 54% |
| Aug 15, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $45 | 44% |
| Aug 15, 2024 | B of A Securities | maintain | Buy → Buy | $31 | 53% |
| Aug 15, 2024 | Barclays | maintain | Overweight → Overweight | $33 | 53% |
| Aug 6, 2024 | JP Morgan | maintain | Overweight → Overweight | $33 | 55% |
| Aug 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $41 | 44% |
Price Target Trend
Jul 10, 2026 Latest: $37.27 Oct 25, 2026
EPS Estimates
0y $-1.98
Lo: $-2.25 Hi: $-1.69
10 analysts +1y $-0.84
Lo: $-1.96 Hi: $0.10
10 analysts 0q $-0.49
Lo: $-0.58 Hi: $-0.38
10 analysts +1q $-0.45
Lo: $-0.60 Hi: $-0.18
10 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days